Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients
(MedPage Today) -- Medicare will cover the weight-loss drug semaglutide (Wegovy) under its Part D drug program for patients with overweight or obesity who have preexisting heart disease and need the drug to prevent heart attacks or strokes, the...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Cardiology | Eating Disorders & Weight Management | Heart | Heart Disease | International Medicine & Public Health | Medicare | Obesity | Stroke | Weight Loss